Becton Dickinson sees FY23 adjusted EPS $11.85-$12.10, consensus $12.19

Sees FY23 revenue $18.6B-$18.8B, consensus $19.37B. The company said, "Revenue guidance assumes base business currency-neutral revenue growth of 5.25% to 6.25%. Base business revenue guidance reflects continued momentum as we execute our BD 2025 growth strategy. In addition, base business revenue guidance includes an anticipated impact of approximately 100 basis points from an acceleration of our simplification and RECODE programs related to planned strategic portfolio exits. This impact is expected to be fully offset by the positive contribution of approximately 100 basis points from the full-year benefit of recent acquisitions, primarily Parata Systems. The revenue guidance range assumes approximately $125 to $175 million in COVID-19-only diagnostic testing revenues. Based on current rates, foreign exchange would represent a reduction of approximately 450 basis points to total company revenue growth. The company expects fiscal year 2023 adjusted diluted EPS to be $11.85 to $12.10. This includes an estimated impact from foreign currency of approximately 420 basis points based on current rates. On a currency-neutral basis, we expect adjusted diluted EPS growth of approximately 9% to 11%."